반고형 제제 수탁제조 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global semi-solid dosage contract manufacturing market size is expected to reach USD 64.06 Billion in 2034 from USD 23.82 Billion in 2025, growing at a CAGR of 11.62 during 2026-2034.This market is witnessing healthy expansion as pharmaceutical companies increasingly outsource the production of creams, ointments, gels, lotions, and topical formulations to specialized manufacturing partners. Rising demand for dermatological products, pain management therapies, and cosmetic pharmaceuticals is encouraging greater reliance on contract manufacturing organizations. Cost optimization and faster product commercialization are also supporting market expansion.

Contract manufacturers are investing in advanced production facilities, automated filling systems, quality assurance technologies, and regulatory compliance to meet evolving pharmaceutical standards. Growing demand for customized formulations and specialized topical drug delivery systems is driving innovation across manufacturing processes. Strategic partnerships between pharmaceutical companies and contract manufacturers are improving production flexibility and operational efficiency.

Future growth is expected to be supported by increasing pharmaceutical outsourcing, expanding biologic-based topical therapies, and continuous investments in advanced manufacturing technologies. Digital quality management systems, automation, and sustainable production practices will improve manufacturing performance. Rising global demand for high-quality topical medicines will continue creating long-term opportunities for contract manufacturing providers.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Topical
• Transdermal
• Oral

By Product

• Creams
• Ointments
• Gels
• Lotions
• Pastes
• Others

By End Use

• Pharmaceutical Companies
• Cosmeceutical Companies
• Others

By Company Size

• Large Size Companies
• Medium & Small Size Companies
• Others

COMPANIES PROFILED

• Lonza Group AG, Lubrizol Life Science, Cambrex Corporation, Contract Pharmaceuticals Limited, Bora Pharmaceuticals Co. Ltd., Ascendia Pharmaceuticals Inc., Pierre Fabre Group, Piramal Pharma Solutions, DPT Laboratories Ltd., MedPharm Ltd, Catalent Inc., Recipharm AB, Aenova Group GmbH, Almac Group Limited

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Transdermal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Creams Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ointments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gels Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Lotions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Pastes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cosmeceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET: BY COMPANY SIZE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Company Size
• 7.2. Large Size Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Medium & Small Size Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Product
  • 8.2.3 By End Use
  • 8.2.4 By Company Size
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Product
  • 8.3.3 By End Use
  • 8.3.4 By Company Size
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Product
  • 8.4.3 By End Use
  • 8.4.4 By Company Size
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Product
  • 8.5.3 By End Use
  • 8.5.4 By Company Size
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Product
  • 8.6.3 By End Use
  • 8.6.4 By Company Size
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Lonza Group AG
  • 10.2.2 Lubrizol Life Science
  • 10.2.3 Cambrex Corporation
  • 10.2.4 Contract Pharmaceuticals Limited
  • 10.2.5 Bora Pharmaceuticals Co. Ltd
  • 10.2.6 Ascendia Pharmaceuticals Inc
  • 10.2.7 Pierre Fabre Group
  • 10.2.8 Piramal Pharma Solutions
  • 10.2.9 DPT Laboratories Ltd
  • 10.2.10 MedPharm Ltd
  • 10.2.11 Catalent Inc
  • 10.2.12 Recipharm AB
  • 10.2.13 Aenova Group GmbH
  • 10.2.14 Almac Group Limited